PROK

ProKidney Corp

1.07

Nov 03 • 3:59 PM ET -0.05 (-4.46%)

1.09

Aftermarket • 7:30 PM ET +0.02 (1.87%)

Healthcare Biotechnology USA Small NASD

Nov 02, 12:02 PM$200M ATM shelf overhang extends ProKidney drop, shares fall 25% Monday

Peers: MAZE CAPR VRTX VERA TVTX MLYS ARDX AZN AKBA DVA

| Held by: IWM VXF SCHA VTWO IWO SURI IWC IWN BBC VTWG

Scroll to Statements

Index	RUT
Market Cap	323.49M
Enterprise Value	1.25B
Income	-84.16M
Sales	0.82M
Book/sh	-4.29
Cash/sh	0.60
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	231
IPO	Jun 30, 2021

P/E	-
Forward P/E	-
PEG	-
P/S	394.50
P/B	-
P/C	1.78
P/FCF	-
EV/EBITDA	-
EV/Sales	1526.61
Quick Ratio	8.36
Current Ratio	8.36
Debt/Eq	-
LT Debt/Eq	-
Option/Short	Yes / Yes

EPS (ttm)	-0.55
EPS next Y	-0.69
EPS next Q	-0.16
EPS this Y	-31.76%
EPS next Y	-1.01%
EPS next 5Y	9.81%
EPS past 3/5Y	33.55% 12.93%
Sales past 3/5Y	- -
EPS Y/Y TTM	2.13%
Sales Y/Y TTM	55.22%
EPS Q/Q	-20.38%
Sales Q/Q	-32.13%
Earnings	Aug 10 AMC
EPS/Sales Surpr.	-7.14% -19.48%

Insider Own	46.34%
Insider Trans	-0.54%
Inst Own	26.38%
Inst Trans	1.80%
ROA	-27.10%
ROE	-
ROIC	-
Gross Margin	-600.61%
Oper. Margin	-21664.55%
Profit Margin	-10288.39%
SMA20	-26.03%
SMA50	-34.97%
SMA200	-40.77%
Trades

Shs Outstand	205.72M
Shs Float	112.11M
Short Float	21.91%
Short Ratio	17.11
Short Interest	24.57M
52W High	3.10 -65.48%
52W Low	0.87 22.96%
Volatility	19.50% 10.16%
ATR (14)	0.14
RSI (14)	28.78
Beta	1.91
Rel Volume	1.09
Avg Volume	1.44M
Volume	1,544,110

Perf Week	-29.37%
Perf Month	-32.28%
Perf Quarter	-35.93%
Perf Half Y	-44.27%
Perf YTD	-52.23%
Perf Year	-62.46%
Perf 3Y	-33.54%
Perf 5Y	-89.26%
Perf 10Y	-
Recom	1.83
Target Price	6.50
Prev Close	1.12
Price	1.07
Change %	-4.46%

Consensus

Buy

Avg. Price Target

$6.50

Implied Upside

+507.5%

Analysts10incl. previous ratings

Rating Distribution7 Buy · 2 Hold · 1 Sell

Date	Action	Analyst	Rating Change	Price Target Change	Implied Upside
Dec 16, 2025	Initiated	HH.C. Wainwright	Buy	$12	+1,021.5%
Jun 30, 2025	Downgrade	BBofA Securities	Neutral → Underperform	$1	-6.5%
Sep 30, 2024	Initiated	JJP Morgan	Neutral
Sep 10, 2024	Initiated	GGuggenheim	Buy	$6	+460.7%
Mar 07, 2024	Resumed	MMorgan Stanley	Equal-Weight	$3	+180.4%
Jan 02, 2024	Downgrade	BBofA Securities	Buy → Neutral
Jul 25, 2023	Initiated	BBTIG Research	Buy	$16	+1,395.3%
Dec 21, 2022	Initiated	JJefferies	Buy	$15	+1,301.9%
Nov 10, 2022	Initiated	MMorgan Stanley	Equal-Weight	$13	+1,115.0%
Oct 18, 2022	Initiated	UUBS	Buy	$18	+1,582.2%
Oct 14, 2022	Initiated	CCitigroup	Buy	$16	+1,395.3%
Sep 23, 2022	Initiated	BBofA Securities	Buy	$14	+1,208.4%
Sep 02, 2022	Initiated	EEvercore ISI	Outperform

Oct-22-26 08:45AM	ProKidney to Host Virtual KOL Event to Recap Mechanism of Action Data Presented at ASN Kidney Week and Provide a Corporate Update (GlobeNewswire)
08:00AM	ProKidney Announces Eight Abstracts Selected for Presentation at the American Society of Nephrology's Kidney Week 2026 (GlobeNewswire)
Oct-02-26 09:00AM	ProKidney Announces Eight Abstracts Selected for Presentation at the American Society of Nephrology's Kidney Week 2026 (GlobeNewswire)
Aug-10-26 04:05PM	ProKidney Reports Second Quarter 2026 Financial Results and Business Highlights (GlobeNewswire)
Jun-02-26 08:00AM	ProKidney Appoints Kenneth Locke as Chief Technical Officer (GlobeNewswire)
11:45AM	Loading…
May-15-26 11:45AM	ProKidney Reports First Quarter 2026 Financial Results and Business Highlights (GlobeNewswire)
Mar-25-26 04:01PM	ProKidney Expands Senior Leadership Team with Appointment of Greg Madison as Chief Commercial Officer (GlobeNewswire)
Mar-18-26 04:00PM	ProKidney Reports Full Year 2025 Financial Results and Business Highlights (GlobeNewswire) -6.25%
Mar-04-26 05:15PM	Aquestive Therapeutics (AQST) Reports Q4 Loss, Misses Revenue Estimates (Zacks) +11.31%
Jan-06-26 07:30AM	ProKidney to Present at the 44th Annual J.P. Morgan Healthcare Conference (GlobeNewswire) +5.14%
Dec-27-25 07:43AM	ProKidney Corp. (PROK) Positioned to Redefine Chronic Kidney Disease Treatment, Believes H.C. Wainwright (Insider Monkey)
Dec-16-25 11:53AM	Beyond Insulin Pumps: Cell Therapies Unlock a $403B Cure Economy (PR Newswire) +5.77%
Nov-10-25 04:15PM	ProKidney Reports Third Quarter 2025 Financial Results and Provides Regulatory and Clinical Updates (GlobeNewswire) -6.57%
Nov-06-25 11:00AM	ProKidney Presents Full Results from the Phase 2 REGEN-007 Trial of Rilparencel at the American Society of Nephrology Kidney Week 2025 (GlobeNewswire)
Oct-29-25 07:30AM	ProKidney to Participate in Two Upcoming Conferences: Guggenheim Healthcare Innovation Conference and the Jefferies Global Healthcare Conference (GlobeNewswire)
07:30AM	Loading…
Oct-20-25 07:30AM	ProKidney Announces Two Abstracts Selected for Presentation at the American Society of Nephrology's Kidney Week 2025 (GlobeNewswire) +10.77%
Sep-20-25 02:43AM	ProKidney Corp (PROK) Touts Reparencel Therapy for Growth (Insider Monkey)
Aug-27-25 07:30AM	ProKidney to Participate in Two Upcoming Conferences: the Citi Biopharma Back to School Conference and the Morgan Stanley Global Healthcare Conference (GlobeNewswire)
Aug-12-25 04:01PM	ProKidney Reports Second Quarter 2025 Financial Results and Provides Regulatory and Clinical Updates (GlobeNewswire) +5.80%
Jul-22-25 11:03AM	ProKidney Corp (PROK) Completes Re-domestication to Delaware amid Kidney Therapy Advancement (Insider Monkey) -5.28%
04:52AM	Meet the Biotech Stock That Rocketed 775% Higher (Motley Fool)
Jul-20-25 12:35AM	JP Morgan Maintains a Neutral Stance on ProKidney Corp. (PROK) (Insider Monkey)
Jul-17-25 12:00PM	PROKIDNEY CP (PROK) Upgraded to Strong Buy: What Does It Mean for the Stock? (Zacks) -5.63%
10:00AM	Best Momentum Stocks to Buy for July 17th (Zacks)
06:40AM	This Biotech Stock Jumped Over 600% in Just Days After Releasing Promising Clinical Trial Data. And Its Market Cap Is Still Only $2 Billion. But Is It a Buy? (Motley Fool)
05:38AM	New Strong Buy Stocks for July 17th (Zacks)
Jul-16-25 12:00PM	ProKidney Corp. (PROK) is a Great Momentum Stock: Should You Buy? (Zacks) +10.68%
Jul-15-25 07:30AM	ProKidney Announces Alignment with the FDA on the Accelerated Approval Pathway for Rilparencel (GlobeNewswire) -8.67%
Jul-14-25 09:45AM	ProKidney Just Set a New 52-Week High. Should You Buy, Sell, or Hold PROK Stock Here? (Barchart) -18.72%
Jul-12-25 07:30AM	'Story' stocks are smoking hot in 2025. This is how it could end badly for investors. (MarketWatch)
12:26PM	Loading…
Jul-09-25 12:26PM	PROK Surges More Than 500% on Upbeat Data From Kidney Cell Therapy Study (Zacks) +16.35%
07:51AM	ProKidney, Meta & EssilorLuxottica, Apple COO: Trending Tickers (Yahoo Finance Video)
07:30AM	ProKidney to Participate in the H.C. Wainwright 4th Annual Kidney Virtual Conference (GlobeNewswire)
Jul-08-25 05:09PM	ProKidney's stock rockets on 'intriguing' news, but analyst doesn't recommend buying (MarketWatch) +515.00%
07:00AM	ProKidney Reports Statistically and Clinically Significant Topline Results for the Phase 2 REGEN-007 Trial Evaluating Rilparencel in Patients with Chronic Kidney Disease and Diabetes (GlobeNewswire)
Jul-01-25 12:43PM	ProKidney Corp. Completes Domestication from the Cayman Islands to Delaware (GlobeNewswire)
Jun-30-25 09:36AM	Circle initiated, Disney upgraded: Wall Street's top analyst calls (The Fly) -11.46%
May-12-25 04:15PM	ProKidney Reports First Quarter 2025 Financial Results and Business Highlights (GlobeNewswire) +15.79%
Mar-21-25 09:55AM	Down -38% in 4 Weeks, Here's Why You Should You Buy the Dip in PROKIDNEY CP (PROK) (Zacks)
Mar-17-25 07:30AM	ProKidney Reports Full Year 2024 Financial Results and Business Highlights (GlobeNewswire) +5.73%
Jan-07-25 07:30AM	ProKidney to Present at the 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Nov-26-24 07:30AM	ProKidney to Participate in Two Upcoming Conferences: Evercore HealthCONx Conference and the Citi Global Healthcare Conference (GlobeNewswire)
Nov-12-24 07:30AM	ProKidney Reports Third Quarter 2024 Financial Results along with Regulatory and Clinical Development Updates Following Successful FDA Type B Meeting (GlobeNewswire)
Nov-05-24 07:30AM	ProKidney to Participate in the Guggenheim Inaugural Healthcare Innovation Conference and the Jefferies London Healthcare Conference (GlobeNewswire)
Oct-22-24 07:02PM	Suvretta Capital Management's Strategic Acquisition in ProKidney Corp (GuruFocus.com) -8.11%
Oct-14-24 07:30AM	ProKidney Announces Five Abstracts Selected for Presentation at the American Society of Nephrology's Kidney Week 2024 (GlobeNewswire)
Oct-09-24 07:30AM	ProKidney to Participate in the UBS Virtual Organ Restoration Day (GlobeNewswire)
Sep-04-24 01:33PM	ProKidney drops Phase III CKD study to focus on US market and save up to $175m (Clinical Trials Arena) -9.17%
Sep-03-24 07:30AM	ProKidney Announces Strategic Updates to its Phase 3 Program to Accelerate Rilparencel's Registrational Path to Potential Approval in the U.S. (GlobeNewswire)
Aug-27-24 07:30AM	ProKidney to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference (GlobeNewswire) -7.53%
Aug-09-24 07:00AM	ProKidney Reports Business Updates and Second Quarter 2024 Financial Results (GlobeNewswire)
Jun-27-24 05:52AM	PROK Stock Earnings: ProKidney Reported Results for Q4 2023 (InvestorPlace) +6.61%
Jun-26-24 02:10PM	Hedge Fund and Insider Trading News: Crispin Odey, Boaz Weinstein, Ken Griffin, Greenlight Capital, Eisler Capital, ProKidney Corp (PROK), Essex Property Trust Inc (ESS), and More (Insider Monkey)
Jun-17-24 07:00AM	ProKidney Announces the Closing of $140 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering, Including Exercise of Underwriters' Option (GlobeNewswire) +6.96%
Jun-11-24 09:35PM	ProKidney Announces Pricing of its Upsized $130 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering (GlobeNewswire) -19.87% +23.55%
07:40AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday (InvestorPlace)
Jun-10-24 04:15PM	ProKidney Announces Proposed $125 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering (GlobeNewswire) -5.33%
07:32AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday (InvestorPlace)
06:30AM	ProKidney Announces Positive Interim REGEN-007 Phase 2 Trial Data and Provides Clinical and Operational Updates (GlobeNewswire)
May-29-24 07:00AM	ProKidney to Participate in the Jefferies Global Healthcare Conference (GlobeNewswire) +6.74%
May-21-24 07:00AM	ProKidney to Host Virtual KOL Event to Discuss Current Treatment Landscape of Chronic Kidney Disease Caused by Diabetes and Data from Phase 2 RMCL-002 Clinical Trial on May 28, 2024 (GlobeNewswire)
May-10-24 03:43PM	ProKidney Corp Reports First Quarter 2024 Financial Results (GuruFocus.com) +7.66%
01:54PM	PROK Stock Earnings: ProKidney Beats EPS for Q1 2024 (InvestorPlace)
07:48AM	ProKidney Q1 Loss Unchanged From Year Earlier (MT Newswires)
07:00AM	ProKidney Reports Business Updates and First Quarter 2024 Financial Results (GlobeNewswire)
Mar-25-24 06:05AM	ProKidney Announces Key Leadership Appointments Strengthening Clinical and Technical Operations (GlobeNewswire)
Mar-21-24 07:49PM	ProKidney Reports Full Year 2023 Financial Results and Recent Corporate Highlights (GlobeNewswire) -6.16%
Feb-29-24 04:05PM	ProKidney to Participate in Jefferies Biotech on the Bay Summit (GlobeNewswire)
Dec-29-23 08:22AM	Chamath Palihapitiya Stocks: 12 Stocks Pumped in the Last 10 Years (Insider Monkey)
Dec-13-23 09:55AM	Here's Why ProKidney Corp. (PROK) Is a Great 'Buy the Bottom' Stock Now (Zacks) +9.60%
Nov-30-23 06:05AM	ProKidney Appoints Nikhil Pereira-Kamath, MBA, as Chief Business Officer (GlobeNewswire) -10.16%
Nov-24-23 06:40AM	7 Penny Stocks With Low Floats and High Short Interest (InvestorPlace)
Nov-21-23 06:05AM	ProKidney to Participate in a Fireside Chat at the Upcoming Evercore ISI 6th Annual HEALTHCONx Conference (GlobeNewswire) +5.68%
Nov-17-23 01:38PM	ProKidney Corp. (NASDAQ:PROK) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-16-23 09:35AM	After Plunging -37.39% in 4 Weeks, Here's Why the Trend Might Reverse for ProKidney Corp. (PROK) (Zacks) -11.51%
Nov-14-23 07:04AM	ProKidney Corp (PROK) Reports Q3 Financial Results: Focus on Chronic Kidney Disease Trials (GuruFocus.com) -5.00%
06:05AM	ProKidney Reports Third Quarter Financial Results (GlobeNewswire)
Nov-13-23 05:02PM	ProKidney Announces Positive Interim Data from RMCL-002 Phase 2 Clinical Trial of Renal Autologous Cell Therapy (REACT ) for Diabetic CKD and Provides Corporate Updates (GlobeNewswire)
Oct-30-23 04:12PM	ProKidney Announces Four Abstracts Selected for Presentation at the American Society of Nephrology's Kidney Week 2023 (GlobeNewswire) +12.29%
Oct-17-23 09:35AM	ProKidney Corp. (PROK) Loses -54.93% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks) -7.93%
Oct-16-23 02:50PM	Is Chamath Palihapitiya Giving Up on ProKidney (PROK) Stock? (InvestorPlace)
Oct-12-23 03:05PM	Why Shares of ProKidney Were Dropping Thursday (Motley Fool) -31.45%
Sep-06-23 12:14PM	ProKidney confirms it will expand HQ complex, add 50 jobs in Winston-Salem (American City Business Journals)
Sep-05-23 06:05AM	ProKidney to Participate in Fireside Chat at the Morgan Stanley Global Healthcare Conference (GlobeNewswire)
Aug-31-23 10:33AM	3 Biotech Stocks Due for a Massive Short Squeeze (InvestorPlace)
Aug-29-23 01:16PM	ProKidney confirmed as company seeking incentives to expand in Forsyth County (American City Business Journals)
Aug-11-23 02:21PM	ProKidney reports $38.8 million loss in Q2 FY2023 as it advances clinical trials and prepares for Greensboro manufacturing expansion (American City Business Journals)
Aug-10-23 04:10PM	ProKidney Reports Second Quarter Financial Results and Recent Corporate Highlights (GlobeNewswire)
Jul-18-23 06:05AM	ProKidney Announces Closing of Purchase of Manufacturing Facility in Greensboro, NC (GlobeNewswire)
Jul-17-23 06:05AM	ProKidney Appoints Bruce Culleton, MD, as Executive Vice President, Clinical Development and Commercialization (GlobeNewswire) +6.65%
Jun-13-23 12:05PM	ProKidney Announces Purchase of Manufacturing Facility in Greensboro, NC (GlobeNewswire)
Jun-01-23 04:05PM	ProKidney to Participate in Fireside Chat at the Jefferies Healthcare Conference (GlobeNewswire) -7.66%
May-11-23 04:01PM	ProKidney Reports First Quarter Financial Results and Recent Corporate Highlights (GlobeNewswire)
May-04-23 06:05AM	ProKidney to Present at the BofA Securities Health Care Conference 2023 (GlobeNewswire)
Apr-25-23 02:00PM	We're Interested To See How ProKidney (NASDAQ:PROK) Uses Its Cash Hoard To Grow (Simply Wall St.) -8.73%
Mar-28-23 04:12PM	ProKidney Reports Fourth Quarter Financial Results and Recent Corporate Highlights (GlobeNewswire) -7.39%
Mar-03-23 06:05AM	ProKidney to Participate in TD Cowens 43rd Annual Health Care Conference (GlobeNewswire)
Jan-11-23 07:48AM	ProKidneys stock jumps 29% (MarketWatch)
Jan-10-23 04:05PM	ProKidney Announces Publication of Trial Design for Phase 2 Multicenter Clinical Trial of REACT for Late Stage 4 Diabetes-Related Chronic Kidney Disease (GlobeNewswire) +9.57%
Dec-27-22 11:05AM	Chamath Palihapitiya Stocks: 10 Stocks Picked in the Last 10 Years (Insider Monkey) -5.82%

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Pereira Brian JG	Director	Aug 19 '26	Sale	1.44	222,949	321,203	222,948	Aug 20 05:00 PM
Pereira Brian JG	Director	Aug 20 '26	Sale	1.42	222,948	316,564	0	Aug 20 05:00 PM
Pereira Brian JG	Director	Aug 18 '26	Sale	1.37	229,338	314,468	445,897	Aug 20 05:00 PM
Pereira Brian JG	Director	Aug 19 '26	Sale	1.44	27,051	38,972	27,052	Aug 20 05:00 PM
Pereira Brian JG	Director	Aug 20 '26	Sale	1.42	27,052	38,411	0	Aug 20 05:00 PM
Pereira Brian JG	Director	Aug 18 '26	Sale	1.37	27,826	38,155	54,103	Aug 20 05:00 PM
Brian Pereira	Director	Aug 18 '26	Proposed Sale	1.40	675,235	945,329		Aug 18 04:42 PM
Brian Pereira	Director	Aug 18 '26	Proposed Sale	1.39	81,929	114,000		Aug 18 04:41 PM
Pereira Brian JG	Director	Nov 13 '25	Sale	2.37	502,136	1,190,062	0	Nov 14 04:07 PM
Pereira Brian JG	Director	Nov 12 '25	Sale	2.72	255,026	694,515	54,333	Nov 14 04:07 PM
Brian Pereira	Director	Nov 12 '25	Proposed Sale	2.70	675,234	1,823,131		Nov 12 04:42 PM
Brian Pereira	Director	Nov 12 '25	Proposed Sale	2.70	81,928	221,205		Nov 12 04:30 PM

ProKidney Corp. is a clinical-stage biotechnology company, which engages in the development of a proprietary cell therapy platform. The firm focuses on the treatment of chronic kidney disease, shifting the emphasis away from management of kidney failure to the restoration of kidney function to stop or delay progression of CKD. It offers REACT, a product candidate that includes selected renal cells prepared from a patient's own, autologous, and renal cells. The company was founded on December 21, 2015 and is headquartered in Winston-Salem, NC.

CEO & DirectorDr. Bruce Culleton M.D.

Chief Financial OfficerMr. James Coulston CPA

J.D.Mr. Todd C. Girolamo Esq.

Chief Technical OfficerMr. Kenneth Locke

Chief Information OfficerMr. Richard Williams

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

PROK

ProKidney Corp

Upgrade your Finviz experience